Scarica l'app Stockscreener
79.90
2.42%
1.89
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CVS Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$78.01
Aprire:
$78.02
Volume 24 ore:
14.70M
Relative Volume:
1.74
Capitalizzazione di mercato:
$101.65B
Reddito:
$402.11B
Utile/perdita netta:
$1.73B
Rapporto P/E:
57.75
EPS:
1.3835
Flusso di cassa netto:
$7.81B
1 W Prestazione:
+4.19%
1M Prestazione:
+10.97%
6M Prestazione:
+11.08%
1 anno Prestazione:
+23.91%
Intervallo 1D:
$77.50
$79.90
Intervallo di 1 settimana:
$72.92
$79.90
Portata 52W:
$58.35
$85.15
Cvs Health Corp Stock (CVS) Company Profile
Nome
Cvs Health Corp
Settore
Industria
Telefono
(401) 765-1500
Indirizzo
ONE CVS DR., WOONSOCKET
Compare CVS vs UNH, CI, ELV, HUM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
79.90 | 99.25B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
UNH
Unitedhealth Group Inc
|
293.27 | 259.67B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CI
Cigna Group
|
289.82 | 76.09B | 216.66B | 6.25B | 7.44B | 22.19 |
|
ELV
Elevance Health Inc
|
320.00 | 71.30B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
190.54 | 22.47B | 126.36B | 1.30B | 1.55B | 10.67 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-14 | Iniziato | Goldman | Buy |
| 2025-08-18 | Aggiornamento | UBS | Neutral → Buy |
| 2025-08-14 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Aggiornamento | Edward Jones | Hold → Buy |
| 2024-12-03 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-05-30 | Iniziato | Robert W. Baird | Neutral |
| 2024-05-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-05-02 | Downgrade | UBS | Buy → Neutral |
| 2024-05-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2023-12-22 | Iniziato | HSBC Securities | Buy |
| 2023-09-19 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Downgrade | Edward Jones | Buy → Hold |
| 2023-05-26 | Iniziato | Piper Sandler | Overweight |
| 2023-04-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Ripresa | Morgan Stanley | Overweight |
| 2022-06-17 | Iniziato | Loop Capital | Buy |
| 2022-05-27 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Iniziato | Goldman | Buy |
| 2021-12-01 | Iniziato | Seaport Research Partners | Buy |
| 2021-05-19 | Iniziato | Wells Fargo | Equal Weight |
| 2021-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2020-09-17 | Iniziato | Piper Sandler | Overweight |
| 2020-07-01 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-05-14 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Ripresa | RBC Capital Mkts | Outperform |
| 2019-09-12 | Iniziato | Deutsche Bank | Buy |
| 2019-06-05 | Aggiornamento | Standpoint Research | Hold → Buy |
| 2019-04-29 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-04-15 | Downgrade | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Reiterato | BofA/Merrill | Buy |
| 2019-03-13 | Iniziato | Bernstein | Outperform |
| 2019-02-20 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Iniziato | UBS | Buy |
| 2018-12-18 | Iniziato | Barclays | Overweight |
| 2018-11-29 | Ripresa | Goldman | Neutral |
| 2018-11-28 | Iniziato | Evercore ISI | Outperform |
| 2018-10-26 | Ripresa | Wolfe Research | Peer Perform |
| 2018-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2018-02-27 | Ripresa | BofA/Merrill | Buy |
| 2018-02-13 | Reiterato | Citigroup | Neutral |
Mostra tutto
Cvs Health Corp Borsa (CVS) Ultime notizie
THE FRIDAY 5: CVS Employees Receive 42% Bonus Boost; Walgreens Cuts Over 600 Jobs - Progressive Grocer
2 Top Healthcare Stocks to Buy in February - The Motley Fool
Seattle Reign land CVS Health as new sponsorBizwomen - The Business Journals
Philly Says PBMs Can't Exit Suit Over Opioid Crisis - Law360
CVS corporate bonuses jump after 25% earnings spike - BenefitsPRO
CVS Caremark Advances Prior Authorization to Get Specialty Medications to Patients Faster - CVS Health
CVS Health Corp (CVS) Stock Price Down 4.79% on Feb 24 - GuruFocus
CVS slides as Medicare Advantage reimbursement outlook weighs on managed-care sentiment - Quiver Quantitative
CVS Significantly Increases Corporate Bonuses Following Record-High Annual Revenue - Progressive Grocer
CVS boosts employee bonuses after beating 2025 profit target - Health Leaders Media
Bearish Sentiment Surrounds CVS (CVS) Amid Active Options Tradin - GuruFocus
CVS employee bonuses surge after beating 2025 profit target - The Boston Globe
CVS Employee Bonuses Surge After Beating 2025 Profit Target - Bloomberg.com
CVS Stock Quote Price and Forecast - CNN
CVS to pay $45M to resolve three lawsuits, AG says - WWLTV.com
Louisiana reaches $45M settlement with CVS Health, AG announces - Yahoo Finance
How CVS Health test-drives better care experiences using generative agents - CVS Health
HighTower Advisors LLC Has $20.08 Million Stake in CVS Health Corporation $CVS - MarketBeat
Pharmacies and Healthcare Stores Market Report 2026-2035: A $1.73 Trillion Market by 2030 with Walgreens Boots Alliance, CVS Health, The Kroger Co, Rite Aid, Loblaw Companies Leading - Yahoo Finance
Seattle Reign land new sponsor ahead of 2026 season - The Business Journals
CVS goes all-in on women's soccer with multi-city field initiative - The Business Journals
Teladoc Q4 Earnings: Can Integrated Care Strength Save Profits? - Finviz
CVS Health Links Pharmacy Scholarships To Valuation Gap And Equity Goals - Yahoo Finance
CVS Expands Support for Women's Soccer with New Partnerships and Investments - GuruFocus
CVS Pharmacy Partners with U.S. Soccer Federation and National Women's Soccer League to Promote Community Health and Wellness - Finviz
CVS Pharmacy community health partnership with U.S. Soccer and National Women's Soccer League - CVS Health
CVS Pharmacy Partners with U.S. Soccer Federation and National Women's Soccer League to Promote Community Health and Wellness – Company AnnouncementFT.com - Financial Times
Readystate Asset Management LP Makes New $1.43 Million Investment in CVS Health Corporation $CVS - MarketBeat
Millions of US Medicare Advantage enrollees forced to switch plans, study finds - Reuters
How CVS Health is supporting heart health through prevention and chronic management - CVS Health
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
CVS puts $5M toward training more homegrown pharmacists in Louisiana - Stock Titan
Advisors Capital Management LLC Acquires 21,589 Shares of CVS Health Corporation $CVS - MarketBeat
NEOS Investment Management LLC Buys 26,158 Shares of CVS Health Corporation $CVS - MarketBeat
Larry Robbins Exits Universal Health Services Inc, Impacting Por - GuruFocus
Here's Why CVS Health (CVS) is a Strong Value Stock - Yahoo Finance
The Top 5 Analyst Questions From CVS Health's Q4 Earnings Call - Finviz
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields - Benzinga
The Top 5 Analyst Questions From CVS Health’s Q4 Earnings Call - Yahoo Finance
UnitedHealth, CVS, Humana Face Double Trouble As Trump's Medicare Cuts Are Just The Start—PBM 'Spread Pricing' Comes Under Fire - AOL.com
$81.32 Bn Clinical Analytics Markets: Analysis by Offering, Source, Use Case, End User - GlobeNewswire Inc.
Here's Why CVS Health (CVS) is a Strong Growth Stock - Yahoo Finance
CVS Health Expands Retail Stores Into Heart Health And Wellness Hubs - Yahoo Finance
Is CVS Health Corporation (CVS) Larry Robbins’ top pick? - Insider Monkey
Is CVS Health Corporation (CVS) Larry Robbins' top pick? - Finviz
Jim Cramer Discusses CVS Health (CVS) In Detail - Finviz
CVS Pharmacy Is Quietly Becoming Your All?in?One Health Hub – Here’s Why It Matters Now - AD HOC NEWS
CVS Health Corporation (NYSE:CVS) is favoured by institutional owners who hold 88% of the company - Yahoo Finance
CVS Pharmacy Is Quietly Becoming Your All?in?One Health Hub — Here’s What Shoppers Are Really Sa - AD HOC NEWS
Humana is said to be near $1B deal for MaxHealth - Modern Healthcare News
Big Health Raises $23.7M from .406 Ventures, AlleyCorp, CVS Ventures, Blue Venture Fund - Behavioral Health Business
Cvs Health Corp Azioni (CVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.35%
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):